Panacea-Sanofi settle first of its kind patent infringement case
Panacea has agreed to forego its claim for damages and rendition of accounts in the proceedings against Sanofi as prayed in the suit it had filed in the Delhi High Court.
sanofi
September 2024
December 2022
December 2021
January 2020
Covid vaccines help Pfizer, BioNTech, Sinovac, Moderna topple powerhouses GSK, Merck, Sanofi
While Pfizer became the largest seller of vaccines in 2021, the second and third spots were taken by BioNTech and Sinovec.
Biocon wins US patent battle against Sanofi on insulin biosimilar
Semglee is the only interchangeable biosimilar to Lantus, used to treat adults with type 2 diabetes and adults and pediatric patients with type 1 diabetes.
Learnings from the Indian pharma industry
The difference between industry-leading firms and the rest is the unrelenting focus of the leading ones on brand creation, production and supply chain processes, and product innovation.
